The Relationship Between Soluble Interleukin-17 Receptor Levels and CD3-Positive T Cells and Lymphocytes in Patients with Sepsis and Their Predictive Clinical Significance
- PMID: 39464344
- PMCID: PMC11505382
- DOI: 10.2147/JIR.S479310
The Relationship Between Soluble Interleukin-17 Receptor Levels and CD3-Positive T Cells and Lymphocytes in Patients with Sepsis and Their Predictive Clinical Significance
Abstract
Background: To assess the relationship between soluble interleukin-17 receptor (sIL-7R) levels and CD3-positive t cells and lymphocytes in patients with sepsis and their predictive clinical significance.
Methods: The study cohort comprised individuals diagnosed with sepsis based on the Third International Consensus Definitions for Sepsis and Septic Shock, treated in the emergency and critical care medicine departments at Beijing Chuiyangliu Hospital and Baoding No. 1 Central Hospital between December 2020 and June 2022. Patient outcomes were classified based on survival or mortality. Biomarkers, including sIL-7R levels and illness severity scores, were documented. All statistical analyses, including predictive modeling and comparisons were carried out using SPSS v.23.0 software and R software.
Results: On the fifth day post-admission, sIL-7R levels significantly decreased in both the survival and death groups, compared with levels on day one (2.09 ± 0.65 vs 1.07 ± 0.53 ng/mL, P < 0.01). There was a significant correlation between the sIL-7R level and the CD3+ T-lymphocyte count (CD3+) (r = 0.44) and lymphocyte count (LYM) (r = 0.42). The combination of the sIL-7R level with the Sequential Organ Failure Assessment (SOFA) score demonstrated optimal predictive value for clinical outcomes in patients with sepsis, demonstrated by an area under the receiver operating characteristic curve of 0.998.
Conclusion: sIL-7R levels are correlated with CD3+ and LYM counts. Additionally, the combination of serum sIL-7R level and SOFA score provides a robust method for predicting sepsis outcomes.
Keywords: immune function; prognosis; sepsis; soluble interleukin-7 receptor.
© 2024 Li et al.
Conflict of interest statement
Authors declare that they have no conflict of interest.
Figures




References
-
- Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: international Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;3(45):486–552. - PubMed
-
- Xu Z, Liu A, Yang L, et al. Changes in immune function and immunomodulatory treatments of septic patients. Clin Immunol. 2022;239:109040. - PubMed
-
- Tao TZ, Zhang GR, Yang XM, et al. Immune checkpoint Vista has a role in the modulation of immune response in the septic mice. Acta Univ Med Anhui. 2022;57(2):193–196,202.
-
- Yang P, DY Fu, Xu B, et al. Research on the correlation between immune indexes and disease severity and prognosis in elderly patients with sepsis. J Med Postgra. 2022;35(12):1298–1303.
LinkOut - more resources
Full Text Sources